CD4 and type 1 diabetes mellitus: The differential expression of miR142-3p was validated by quantitative polymerase chain reaction (qPCR) analysis of activated CD4+ T cells isolated from peripheral blood of individuals without T1D and with recent onset of T1D (Fig. 1g).